IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i13p6717-d579653.html
   My bibliography  Save this article

Developmental Neurotoxicity of Environmentally Relevant Pharmaceuticals and Mixtures Thereof in a Zebrafish Embryo Behavioural Test

Author

Listed:
  • Alessandro Atzei

    (National Institute for Public Health and the Environment (RIVM), 3721 AB Bilthoven, The Netherlands)

  • Ingrid Jense

    (National Institute for Public Health and the Environment (RIVM), 3721 AB Bilthoven, The Netherlands)

  • Edwin P. Zwart

    (National Institute for Public Health and the Environment (RIVM), 3721 AB Bilthoven, The Netherlands)

  • Jessica Legradi

    (Environment & Health, VU University Amsterdam, 1081 HV Amsterdam, The Netherlands)

  • Bastiaan J. Venhuis

    (National Institute for Public Health and the Environment (RIVM), 3721 AB Bilthoven, The Netherlands)

  • Leo T.M. van der Ven

    (National Institute for Public Health and the Environment (RIVM), 3721 AB Bilthoven, The Netherlands)

  • Harm J. Heusinkveld

    (National Institute for Public Health and the Environment (RIVM), 3721 AB Bilthoven, The Netherlands
    These authors contributed equally.)

  • Ellen V.S. Hessel

    (National Institute for Public Health and the Environment (RIVM), 3721 AB Bilthoven, The Netherlands
    These authors contributed equally.)

Abstract

Humans are exposed daily to complex mixtures of chemical substances via food intake, inhalation, and dermal contact. Developmental neurotoxicity is an understudied area and entails one of the most complex areas in toxicology. Animal studies for developmental neurotoxicity (DNT) are hardly performed in the context of regular hazard studies, as they are costly and time consuming and provide only limited information as to human relevance. There is a need for a combination of in vitro and in silico tests for the assessment of chemically induced DNT in humans. The zebrafish ( Danio rerio ) embryo (ZFE) provides a powerful model to study DNT because it shows fast neurodevelopment with a large resemblance to the higher vertebrate, including the human system. One of the suitable readouts for DNT testing in the zebrafish is neurobehaviour (stimulus-provoked locomotion) since this provides integrated information on the functionality and status of the entire nervous system of the embryo. In the current study, environmentally relevant pharmaceuticals and their mixtures were investigated using the zebrafish light-dark transition test. Zebrafish embryos were exposed to three neuroactive compounds of concern, carbamazepine (CBZ), fluoxetine (FLX), and venlafaxine (VNX), as well as their main metabolites, carbamazepine 10,11-epoxide (CBZ 10,11E), norfluoxetine (norFLX), and desvenlafaxine (desVNX). All the studied compounds, except CBZ 10,11E, dose-dependently inhibited zebrafish locomotor activity, providing a distinct behavioural phenotype. Mixture experiments with these pharmaceuticals identified that dose addition was confirmed for all the studied binary mixtures (CBZ-FLX, CBZ-VNX, and VNX-FLX), thereby supporting the zebrafish embryo as a model for studying the cumulative effect of chemical mixtures in DNT. This study shows that pharmaceuticals and a mixture thereof affect locomotor activity in zebrafish. The test is directly applicable in environmental risk assessment; however, further studies are required to assess the relevance of these findings for developmental neurotoxicity in humans.

Suggested Citation

  • Alessandro Atzei & Ingrid Jense & Edwin P. Zwart & Jessica Legradi & Bastiaan J. Venhuis & Leo T.M. van der Ven & Harm J. Heusinkveld & Ellen V.S. Hessel, 2021. "Developmental Neurotoxicity of Environmentally Relevant Pharmaceuticals and Mixtures Thereof in a Zebrafish Embryo Behavioural Test," IJERPH, MDPI, vol. 18(13), pages 1-19, June.
  • Handle: RePEc:gam:jijerp:v:18:y:2021:i:13:p:6717-:d:579653
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/13/6717/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/18/13/6717/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:13:p:6717-:d:579653. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.